NCT03002142

Auditory Rehabilitation and Cognition in Alzheimer Patients

Auditory Rehabilitation With Hearing Aids and Cognition in Alzheimer Patients

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 9 (actual)
• Sponsor: University Hospital, Tours · Academic / Other
• Sex: All
• Age: 65 Years
• Healthy volunteers: Not accepted

Summary

Alzheimer disease is a neurodegenerative disease. Recent studies suggest that subjects with hearing loss are more likely to develop Alzheimer's disease. Hearing loss can be consecutive to presbycusis and/or to central auditory dysfunction. Standard audiometric measures with pure tone and speech intelligibility allow the diagnosis of presbycusis. However, to demonstrate central auditory dysfunction, specific audiometric tests as noisy and/or dichotic tests, are needed. Actually, no consensus exists to investigate hearing loss in people with Alzheimer's disease; therefore hearing loss may be an early manifestation of Alzheimer's disease. Until now, investigations and clinical procedure related to the diagnosis of Alzheimer's disease ignored the hearing ability of the patient. However, the major part of care management and investigations implies the patient's communication ability with caregivers. Hearing loss may be one of the most unrecognized deficit in subjects with Alzheimer's disease. Auditory rehabilitation with hearing aids could benefit to the patient to decrease cognitive decline but this management must be investigate during longitudinal studies in order to demonstrate their efficiency and need to be compared with a placebo.

Conditions

• Alzheimer's Disease
• Hearing Loss

Interventions

Type	Name	Description
DEVICE	Hearing aids	Phonak Audéo B-R (Target V 5.0)
DEVICE	Placebo	Phonak Audéo B-R (Target V 5.0) without amplification

Timeline

• Start date: 2017-03-31
• Primary completion: 2020-03-03
• Completion: 2020-05-03
• First posted: 2016-12-23
• Last updated: 2021-05-12

Locations

1 site across 1 country: France